Evidence map›Paper›PMID 40081657›Full record

ArticleChest2025

Contribution of Peripheral Airways Dysfunction to Poor Quality of Life in Sarcoidosis.

Dimitrios Toumpanakis, Konstantinos Karagiannis, Paolo Paredi, Andras Bikov, Martina Bonifazi, Harpreet K Lota, Harpal Kalsi, Cosetta Minelli, Nikolaos Dikaios, George A Kastis and 4 more

Abstract read
In one paragraph

Article in Chest, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. WASOG Clinical Trial Endpoint Task Force: Executive Summary.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dimitrios ToumpanakisNational Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, United Kingdom; Second Department of Critical Care Medicine, "Attikon" University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Konstantinos KaragiannisInterstitial Lung Disease Unit, Imperial College London and Royal Brompton Hospital, London, United Kingdom.
Paolo ParediNational Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, United Kingdom.
Andras BikovNational Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Martina BonifaziInterstitial Lung Disease Unit, Imperial College London and Royal Brompton Hospital, London, United Kingdom; Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy; Interstitial Lung Diseases, Pleural and Bronchiectasis Unit, Marche University Hospital, Ancona, Italy.
Harpreet K LotaInterstitial Lung Disease Unit, Imperial College London and Royal Brompton Hospital, London, United Kingdom.
Harpal KalsiNational Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, United Kingdom.
Cosetta MinelliInterstitial Lung Disease Unit, Imperial College London and Royal Brompton Hospital, London, United Kingdom.
Nikolaos DikaiosMathematics Research Centre, Academy of Athens, Athens, Greece.
George A KastisMathematics Research Centre, Academy of Athens, Athens, Greece.
Peter J BarnesNational Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, United Kingdom.
Athol U WellsInterstitial Lung Disease Unit, Imperial College London and Royal Brompton Hospital, London, United Kingdom.
Omar S UsmaniNational Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, United Kingdom. Electronic address: o.usmani@imperial.ac.uk.
Elisabetta A RenzoniInterstitial Lung Disease Unit, Imperial College London and Royal Brompton Hospital, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcoidosis is characterized by reduced quality of life (QoL), yet QoL is correlated poorly to conventional spirometric lung function tests. RESEARCH QUESTION: What is the relationship of a QoL measure with comprehensive lung function assessment using oscillometry in sarcoidosis? STUDY DESIGN AND

methodsSixty-two patients with pulmonary sarcoidosis completed the St. George's Respiratory Questionnaire (SGRQ), a respiratory QoL measure, and underwent lung function assessment including oscillometry, spirometry, diffusion capacity, fractional exhaled nitric oxide (Feno), and body plethysmography. Relationships of lung function parameters with SGRQ results were determined with Spearman rank coefficient (ρ), and receiver operating characteristic curves were plotted. Logistic regression and hierarchy cluster analysis of parameters from multiple lung function techniques were performed.

resultsOscillometric indices describing peripheral lung dysfunction showed significant associations with SGRQ score (resistance at 5 Hz [R5], ρ = 0.43 [P < .01]; R5 minus resistance at 20 Hz [R20], ρ = 0.35 [P < .01]; reactance at 5 Hz [X5], ρ = -0.42 [P < .01]; reactance area under the curve [Ax], ρ = 0.44 [P < .01]), whereas FVC % predicted and residual volume to total lung capacity ratio, were related weakly to SGRQ score (ρ = -0.30 [P = .02] and ρ = 0.30 [P = .02], respectively). Oscillometry reactance, measuring elastic properties of the lung, predicted an impaired QoL (area under the receiver operating characteristic curve: Ax, 0.80 [P < .001] and X5, 0.78 [P < .001]), even in patients with absence of an obstructive or restrictive spirometry pattern. Ax remained associated significantly with SGRQ score even after adjustment for FVC and Scadding stage on multivariable analysis (P = .005). Feno was not associated with SGRQ score. Peripheral airway function parameters (R5 minus R20, Ax, and residual volume to total lung capacity ratio) were grouped in an independent cluster, whereas X5 constituted a single cluster.

interpretationOur results indicate that oscillometric lung function parameters, especially those of peripheral airway dysfunction, are correlated more strongly to a QoL measure than spirometry in patients with sarcoidosis.

Indexed as

LungQuality of LifeSarcoidosis, PulmonaryAdultFemaleHumansMaleMiddle AgedOscillometryPlethysmography, Whole BodyRespiratory Function TestsROC CurveSpirometrySurveys and Questionnairesexhaled nitric oxidelung functionoscillometryperipheral airwaysquality of lifesarcoidosis

Identifiers

PMID40081657
PMCPMC12405914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.